Chirag Shah
Retina Specialist · San Diego, CANPI 1023472560
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,600 of the $15,849 with a category attached, or 66.9%. AbbVie accounts for 70.5% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $10,866, more than ten times the $400 reported in 2020.
Across 118 payments — averaging $134.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$11K
- Regeneron$1K
- Amgen$907
- Alcon$456
- Alimera Sciences, Inc.$360
- Astellas Pharma US Inc$250
- plus $2K from 20 others
What the payments were for
- Consulting fees$10,60067%
- Travel & lodging$9206%
- Food & beverage$4,28427%
- Entertainment$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $11,167 |
| Regeneron | 1 | $1,100 |
| Amgen(2 entities) | 20 | $907 |
| Alcon | 12 | $456 |
| Alimera Sciences, Inc. | 6 | $360 |
| Astellas Pharma US Inc | 10 | $250 |
| Genentech USA, Inc. | 7 | $234 |
| Apellis Pharmaceuticals, Inc. | 4 | $190 |
| Bausch & Lomb Americas Inc. | 4 | $185 |
| Glaukos Corporation | 2 | $146 |
| Sight Sciences, Inc. | 1 | $146 |
| Topcon Healthcare, Inc. | 2 | $132 |
| GSK | 2 | $115 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $55 |
| Dutch Ophthalmic, USA | 2 | $52 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $50 |
| Optos, Inc. | 1 | $45 |
| Carl Zeiss Meditec USA, Inc. | 1 | $44 |
| ANI Pharmaceuticals, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Eyepoint US, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $29 |
| Harrow Eye, LLC | 1 | $27 |
| Lombart Brothers, Inc. | 1 | $23 |
| Coherus Oncology, Inc. | 1 | $16 |
| Ocular Therapeutix, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,849 in reported general payments places this provider in the 75th percentile of 187 retina specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 76 | $2,032 |
| Ofloxacin | 39 | $361 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 21 | $337 |
| Ketorolac Tromethamine | 39 | $323 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 41 | $307 |
| Latanoprost | 12 | $143 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in San Diego
- Thomas LazzariniSan Diego$15K
- Jason MossSan Diego$11K
- Delu SongSan Diego$10K
- Dilsher DhootSanta Barbara$1.9M
- Ehsan RahimyStanford$1.5M
- Darius MoshfeghiPalo Alto$1.4M
- Nathan SteinleSanta Barbara$1.1M
- Roger GoldbergWalnut Creek$1.1M
- Baruch KuppermannIrvine$1M
- Carlos Medina MendezSacramento$548K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.